Filing Details
- Accession Number:
- 0001493152-21-008584
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-12 19:55:03
- Reporting Period:
- 2021-04-12
- Accepted Time:
- 2021-04-12 19:55:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710340 | Eton Pharmaceuticals Inc. | ETON | Pharmaceutical Preparations (2834) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1360214 | Harrow Health, Inc. | 102 Woodmont Blvd. Suite 610 Nashville TN 37205 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-12 | 1,518,000 | $7.00 | 1,982,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- On April 12, 2021, Harrow Health, Inc., a Delaware corporation (the "Company"), closed the previously announced underwritten public offering of 1,518,000 shares of common stock of Eton Pharmaceuticals, Inc. at a public offering price of $7.00 per share, including 198,000 shared issued pursuant to the full exercise by the underwriter, National Securities Corporation, of its over-allotment option. The gross proceeds to the Company from the offering were approximately $10.6 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company.
Billionaire Hedge Funds
